JP2006067801A - Bone component-increasing composition composed of soybean germ-containing bean curd, and functional food containing the composition - Google Patents
Bone component-increasing composition composed of soybean germ-containing bean curd, and functional food containing the composition Download PDFInfo
- Publication number
- JP2006067801A JP2006067801A JP2004247411A JP2004247411A JP2006067801A JP 2006067801 A JP2006067801 A JP 2006067801A JP 2004247411 A JP2004247411 A JP 2004247411A JP 2004247411 A JP2004247411 A JP 2004247411A JP 2006067801 A JP2006067801 A JP 2006067801A
- Authority
- JP
- Japan
- Prior art keywords
- roasted
- okara
- bone
- germ
- functional food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000010469 Glycine max Nutrition 0.000 title claims abstract description 96
- 244000068988 Glycine max Species 0.000 title claims abstract description 93
- 239000000203 mixture Substances 0.000 title claims abstract description 81
- 210000000988 bone and bone Anatomy 0.000 title claims abstract description 78
- 235000013376 functional food Nutrition 0.000 title claims abstract description 22
- 235000013527 bean curd Nutrition 0.000 title claims abstract description 11
- 230000001737 promoting effect Effects 0.000 claims abstract description 16
- 235000009508 confectionery Nutrition 0.000 claims description 19
- 238000001035 drying Methods 0.000 claims description 19
- 235000013305 food Nutrition 0.000 claims description 15
- 239000004480 active ingredient Substances 0.000 claims description 11
- 230000002708 enhancing effect Effects 0.000 claims description 11
- 235000013361 beverage Nutrition 0.000 claims description 9
- 241000251468 Actinopterygii Species 0.000 claims description 7
- 201000010099 disease Diseases 0.000 claims description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 6
- 230000002265 prevention Effects 0.000 claims description 6
- 235000013618 yogurt Nutrition 0.000 claims description 6
- 235000008429 bread Nutrition 0.000 claims description 5
- 238000002036 drum drying Methods 0.000 claims description 5
- 235000013322 soy milk Nutrition 0.000 claims description 5
- 235000014121 butter Nutrition 0.000 claims description 4
- 235000015218 chewing gum Nutrition 0.000 claims description 4
- 229940112822 chewing gum Drugs 0.000 claims description 4
- 235000011194 food seasoning agent Nutrition 0.000 claims description 4
- 235000003599 food sweetener Nutrition 0.000 claims description 4
- 235000012149 noodles Nutrition 0.000 claims description 4
- 239000003765 sweetening agent Substances 0.000 claims description 4
- 244000247812 Amorphophallus rivieri Species 0.000 claims description 3
- 235000001206 Amorphophallus rivieri Nutrition 0.000 claims description 3
- 240000008620 Fagopyrum esculentum Species 0.000 claims description 3
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims description 3
- 229920002752 Konjac Polymers 0.000 claims description 3
- 240000008415 Lactuca sativa Species 0.000 claims description 3
- 244000294411 Mirabilis expansa Species 0.000 claims description 3
- 235000015429 Mirabilis expansa Nutrition 0.000 claims description 3
- 235000012970 cakes Nutrition 0.000 claims description 3
- 235000013351 cheese Nutrition 0.000 claims description 3
- 235000016213 coffee Nutrition 0.000 claims description 3
- 235000013353 coffee beverage Nutrition 0.000 claims description 3
- 235000014510 cooky Nutrition 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 235000013365 dairy product Nutrition 0.000 claims description 3
- 235000015071 dressings Nutrition 0.000 claims description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 3
- 235000015110 jellies Nutrition 0.000 claims description 3
- 239000000252 konjac Substances 0.000 claims description 3
- 235000010485 konjac Nutrition 0.000 claims description 3
- 235000010746 mayonnaise Nutrition 0.000 claims description 3
- 239000008268 mayonnaise Substances 0.000 claims description 3
- 235000013336 milk Nutrition 0.000 claims description 3
- 239000008267 milk Substances 0.000 claims description 3
- 210000004080 milk Anatomy 0.000 claims description 3
- 235000013536 miso Nutrition 0.000 claims description 3
- 235000011962 puddings Nutrition 0.000 claims description 3
- 235000019685 rice crackers Nutrition 0.000 claims description 3
- 235000012045 salad Nutrition 0.000 claims description 3
- 235000013580 sausages Nutrition 0.000 claims description 3
- 235000013555 soy sauce Nutrition 0.000 claims description 3
- 235000011496 sports drink Nutrition 0.000 claims description 3
- 239000004278 EU approved seasoning Substances 0.000 claims description 2
- 239000008274 jelly Substances 0.000 claims description 2
- 241001494479 Pecora Species 0.000 claims 1
- 239000000284 extract Substances 0.000 abstract description 34
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 15
- 239000011575 calcium Substances 0.000 abstract description 15
- 229910052791 calcium Inorganic materials 0.000 abstract description 15
- 230000001965 increasing effect Effects 0.000 abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 11
- 244000052616 bacterial pathogen Species 0.000 abstract description 9
- 239000002994 raw material Substances 0.000 abstract description 9
- 230000032683 aging Effects 0.000 abstract description 6
- 230000037396 body weight Effects 0.000 abstract description 6
- 230000011164 ossification Effects 0.000 abstract description 6
- 230000015572 biosynthetic process Effects 0.000 abstract description 4
- 230000001054 cortical effect Effects 0.000 abstract description 3
- 239000007788 liquid Substances 0.000 abstract description 2
- 238000012545 processing Methods 0.000 abstract description 2
- 230000008520 organization Effects 0.000 abstract 2
- 210000001694 thigh bone Anatomy 0.000 abstract 1
- 239000000047 product Substances 0.000 description 26
- 230000000694 effects Effects 0.000 description 22
- 241000700159 Rattus Species 0.000 description 20
- 239000000843 powder Substances 0.000 description 17
- 238000004519 manufacturing process Methods 0.000 description 13
- 238000000034 method Methods 0.000 description 13
- 244000075850 Avena orientalis Species 0.000 description 12
- 235000007319 Avena orientalis Nutrition 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 7
- 229930182490 saponin Natural products 0.000 description 7
- 150000007949 saponins Chemical class 0.000 description 7
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 6
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 6
- 208000020084 Bone disease Diseases 0.000 description 6
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N Daidzein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 6
- 208000001132 Osteoporosis Diseases 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 210000003275 diaphysis Anatomy 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 244000269722 Thea sinensis Species 0.000 description 4
- 230000003262 anti-osteoporosis Effects 0.000 description 4
- 235000019688 fish Nutrition 0.000 description 4
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000007602 hot air drying Methods 0.000 description 4
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 4
- 235000008696 isoflavones Nutrition 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 235000013616 tea Nutrition 0.000 description 4
- 210000000689 upper leg Anatomy 0.000 description 4
- 208000006386 Bone Resorption Diseases 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 230000024279 bone resorption Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 3
- 235000015243 ice cream Nutrition 0.000 description 3
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 229930188627 soysaponin Natural products 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 229940124597 therapeutic agent Drugs 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 2
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 2
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 108010001441 Phosphopeptides Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 229930187719 Soyasaponin Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- PFRQBZFETXBLTP-UHFFFAOYSA-N Vitamin K2 Natural products C1=CC=C2C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000018678 bone mineralization Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 235000007240 daidzein Nutrition 0.000 description 2
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 238000002224 dissection Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 235000006539 genistein Nutrition 0.000 description 2
- 229940045109 genistein Drugs 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- DKHGMERMDICWDU-GHDNBGIDSA-N menaquinone-4 Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 DKHGMERMDICWDU-GHDNBGIDSA-N 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 210000000963 osteoblast Anatomy 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000004804 polysaccharides Chemical class 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 229940107524 soy germ Drugs 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- -1 true arc Substances 0.000 description 2
- 235000019143 vitamin K2 Nutrition 0.000 description 2
- 239000011728 vitamin K2 Substances 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
- SMRPGWBDLOQHOS-UHFFFAOYSA-N 5-[4,5-dihydroxy-6-(hydroxymethyl)-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxy-3,4-dihydroxy-6-[[9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1H-picen-3-yl]oxy]oxane-2-carboxylic acid Chemical compound OC1C(O)C(O)C(C)OC1OC1C(OC2C(OC(C(O)C2O)C(O)=O)OC2C(C3C(C4C(C5(CCC6(C)C(O)CC(C)(C)CC6C5=CC4=O)C)(C)CC3)(C)CC2)(C)CO)OC(CO)C(O)C1O SMRPGWBDLOQHOS-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- KFFJPIQLAPHYBF-UHFFFAOYSA-N Azukisaponin V Natural products COC(=O)C1OC(OC2CCC3(C)C(CCC4(C)C3CC=C5C6CC(C)(C)CC(O)C6(O)CCC45C)C2(C)CO)C(OC7OC(CO)C(O)C(O)C7OC8OC(C)C(O)C(O)C8O)C(O)C1O KFFJPIQLAPHYBF-UHFFFAOYSA-N 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010065687 Bone loss Diseases 0.000 description 1
- 102000055006 Calcitonin Human genes 0.000 description 1
- 108060001064 Calcitonin Proteins 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 208000013558 Developmental Bone disease Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- ZCOLJUOHXJRHDI-FZHKGVQDSA-N Genistein 7-O-glucoside Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)c1cc(O)c2C(=O)C(c3ccc(O)cc3)=COc2c1 ZCOLJUOHXJRHDI-FZHKGVQDSA-N 0.000 description 1
- CJPNHKPXZYYCME-UHFFFAOYSA-N Genistin Natural products OCC1OC(Oc2ccc(O)c3OC(=CC(=O)c23)c4ccc(O)cc4)C(O)C(O)C1O CJPNHKPXZYYCME-UHFFFAOYSA-N 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000029725 Metabolic bone disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 206010049088 Osteopenia Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- YCUNGEJJOMKCGZ-UHFFFAOYSA-N Pallidiflorin Natural products C1=CC(OC)=CC=C1C1=COC2=CC=CC(O)=C2C1=O YCUNGEJJOMKCGZ-UHFFFAOYSA-N 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 206010072610 Skeletal dysplasia Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- XFXHYKZIZSNVSQ-TZRAUYBZSA-N Soyasaponin A1 Chemical compound O([C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@H]1O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@H]5CC([C@H]([C@@H](O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O7)O)[C@@H](O)CO6)O)[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@H]2[C@]1(CO)C)O)(C)C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O XFXHYKZIZSNVSQ-TZRAUYBZSA-N 0.000 description 1
- JFHRJMPZZYINAI-UHFFFAOYSA-N Soyasaponin I Natural products CC1OC(OC2C(O)C(O)C(CO)OC2OC3C(O)C(O)C(CO)OC3OC4CCC5(C)C(CCC6(C)C5CC=C7C8CC(C)(C)CC(O)C8(C)CCC67C)C4(C)CO)C(O)C(O)C1O JFHRJMPZZYINAI-UHFFFAOYSA-N 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000007982 barbital buffer Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000004097 bone metabolism Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229960004015 calcitonin Drugs 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 238000012754 cardiac puncture Methods 0.000 description 1
- 230000008618 cell wall macromolecule catabolic process Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 239000000039 congener Substances 0.000 description 1
- 235000012495 crackers Nutrition 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- 235000019503 curry powder Nutrition 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 238000009806 oophorectomy Methods 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 208000005368 osteomalacia Diseases 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 208000001685 postmenopausal osteoporosis Diseases 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000020185 raw untreated milk Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 235000012046 side dish Nutrition 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- PTDAHAWQAGSZDD-IOVCITQVSA-N soyasaponin I Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H](O[C@@H]([C@@H](O)[C@@H]2O)C(O)=O)O[C@@H]2[C@]([C@H]3[C@]([C@@H]4[C@@]([C@@]5(CC[C@@]6(C)[C@H](O)CC(C)(C)C[C@H]6C5=CC4)C)(C)CC3)(C)CC2)(C)CO)O[C@H](CO)[C@H](O)[C@@H]1O PTDAHAWQAGSZDD-IOVCITQVSA-N 0.000 description 1
- 229940069755 soybean germ extract Drugs 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 235000013547 stew Nutrition 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000010491 tara gum Nutrition 0.000 description 1
- 239000000213 tara gum Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Beans For Foods Or Fodder (AREA)
Abstract
Description
本発明は、焙煎したおからと焙煎した大豆胚芽との混合物を有効成分とする骨重増進組成物及び骨重量増進組成物を含む機能性食品に関する。 The present invention relates to a bone weight enhancing composition containing a mixture of roasted okara and roasted soybean germ as an active ingredient and a functional food containing a bone weight enhancing composition.
一般的におからは豆腐を製造する過程で豆乳を取るためにすりつぶした大豆の絞りかすであるが、その成分は豊富な栄養素を含んでおり、このおからを利用した従来技術として、乳飲料については、例えば、おからを乾燥処理する工程と、乾燥後のおからを焙煎処理する工程を備えたことを特徴とするおから茶の製造法(例えば、特許文献1参照)や、おからに水を加えて撹拌した後、ろ過または遠心分離して抽出液を得る工程と、この抽出液に糖類を0.3〜10.0重量%添加し、PHを3.5〜8.0に調製する工程と、この抽出液を減菌処理する工程と、この抽出液に乳酸菌を撹拌して培養する工程とを含むことを特徴とするおからを原料とする乳酸飲料の製造法(例えば、特許文献2参照)や、乾燥オカラの粉末と,糖質、脂質、タンパク質、無機質及びビタミンの五大栄養素のうちの一つ又は二つ以上の粉末と,味付けの粉末と,水に溶けやすくする性質をもった物質の粉末と,を混合することからなる乾燥オカラの粉末を主成分とした粉末飲料(例えば、特許文献3参照)や、(1)機械的に切断されたおから繊維、(2)おから繊維からなるマトリックス中の繊維間物質の水可溶性多糖類、(3)寒天、キサンタンガム、ジェランガム、グルコマンナン、アルギン酸、グアガム、タラガム、カラギーナンκ、カラギーナンλ、大豆多糖類及びカードランからなる群から選ばれる1種以上の増粘剤、及び(4)水を含有するおから飲料(例えば、特許文献4参照)や、おからを乾燥させた後、一旦パウダー状の微粉末とし、前記微粉末粉を焙煎処理したことを特徴とするおからパウダー茶の製造方法(例えば、特許文献5参照)が、それぞれ知られている。 Generally, okara is a squeezed soybean meal that is ground to remove soy milk in the process of producing tofu, but its ingredients contain abundant nutrients. For example, a method for producing okara tea comprising a step of drying okara and a step of roasting okara after drying (see, for example, Patent Document 1), After adding water and stirring, the step of obtaining an extract by filtering or centrifuging, adding 0.3 to 10.0% by weight of saccharides to this extract, and adding PH to 3.5 to 8.0 A method for producing a lactic acid beverage using okara as a raw material (for example, a step of sterilizing the extract, and a step of stirring and culturing lactic acid bacteria in the extract (for example, , Patent Document 2), dry okara powder, carbohydrates, lipids, A dry okara consisting of a mixture of one, two or more of the five major nutrients of protein, minerals and vitamins, a seasoned powder and a powder of a substance that is easily soluble in water. Powdered beverages based on powder (for example, see Patent Document 3), (1) mechanically cut okara fibers, (2) water-soluble polysaccharides of interfiber substances in a matrix composed of okara fibers (3) one or more thickeners selected from the group consisting of agar, xanthan gum, gellan gum, glucomannan, alginic acid, guar gum, tara gum, carrageenan κ, carrageenan λ, soybean polysaccharide and curdlan, and (4) water Okara beverage (see, for example, Patent Document 4) containing oats, dried okara, and then once powdered into a fine powder, the fine powder is roasted The method of manufacturing okara powder tea (e.g., see Patent Document 5) are known, respectively.
また、食品用としては、含水率80%の生オカラを多量に乾燥せしめ、又圧縮プレスに電気加熱器を取付け、水分を導電媒体として圧縮しながら加熱せしめて水分を蒸気化せしめた後、真空減圧乾燥器で急速乾燥を行い、この粉末を基材として乾燥野菜と螺旋状水藻を混合し、更に甘味料、青ノリ、花粉、田七、ガンマ油、真弧、ハトムギ粉、酵母や酵母を添加した接合剤のアルギニン酸ソーダー、キチンキトサンの酸性液や澱粉を添加して成型して、各種錠剤や丸薬や顆粒状粉に加工した健康食品、飼料加工品、飲料加工品(例えば、特許文献6参照)や、おからと1種または2種以上の澱粉質材料とを含む混合原料を麹菌によって発酵させてなることを特徴とするおから加工食品(例えば、特許文献7参照)や、オカラを植物細胞壁分解酵素の存在下で乳酸発酵してなる乳酸発酵オカラ(例えば、特許文献8参照)が、それぞれ知られている。さらに、焙煎した大豆胚軸及び焙煎したおからを含有するおから茶(例えば、特許文献9参照)が知られている。 For food use, raw okara with a moisture content of 80% is dried in a large amount, and an electric heater is attached to a compression press and heated while compressing moisture as a conductive medium to evaporate the moisture, and then vacuumed. Quick drying in a vacuum dryer, using this powder as a base material, mix dried vegetables and spiral algae, and then add sweetener, green paste, pollen, rice noodles, gamma oil, true arc, pearl flour, yeast and yeast. Health foods, feed processed products, processed beverage products (for example, patent documents) processed by adding various kinds of tablets, pills, and granular powders after adding the added binder soda arginate and chitin chitosan acid solution and starch. 6), or a mixed raw material containing okara and one or more starchy materials, fermented by koji mold, and processed from okara (for example, see Patent Document 7), okara Plant cell wall degradation Lactic acid fermentation Okara obtained by lactic acid fermentation in the presence of oxygen (e.g., see Patent Document 8) have been known, respectively. Furthermore, okara tea containing roasted soybean hypocotyl and roasted okara (see, for example, Patent Document 9) is known.
他方、骨代謝、骨形成不全により、骨中のカルシウム量の減少などが生じて、種々の骨疾患が起こると考えられている。骨疾患の代表として骨折、骨軟化症、骨減少症、骨粗鬆症、腰背痛等がある。特にこれら骨疾患の中でも骨粗鬆症は、加齢による骨吸収と骨形成のバランスが崩れることで、相対的に骨吸収が優位となるために骨量の減少が起こり、骨の微細構造の変化により骨の強度が低下し、骨折が起こりやすくなる病態を示す。特に女性の場合には、閉経や卵巣摘除などにより骨量の減少は急速に起こる。骨粗鬆症になると、骨折したり、激しい痛みなどを伴うだけでなく、特に老人の寝たきりの原因ともなるため、高齢化社会における生活の質の向上という観点からも、有効な治療法が求められている。骨粗鬆症は発症してから治療するのは困難であることから、予防に努めることが重要であり、若年期から骨量を増やすことが不可欠で、日常的に骨形成に必要な栄養成分や、骨形成を促進する食品を積極的に摂取するようにしなければならないことが深く認識されるようになった。骨を強化する食品としては、現在、主にカルシウムやマグネシウム、ビタミンDが利用されている。また、カルシウムの腸管からの吸収を促進するカゼインホスホペプチドなども利用されている。 On the other hand, it is considered that various bone diseases occur due to a decrease in the amount of calcium in bone due to bone metabolism and bone dysplasia. Representative bone diseases include fractures, osteomalacia, osteopenia, osteoporosis, and back pain. Among these bone diseases, in particular, osteoporosis is caused by the loss of bone mass due to the relative dominance of bone resorption due to the imbalance between bone resorption and bone formation due to aging. It shows a pathological condition in which the strength of the bones decreases and fractures are likely to occur. Especially in women, bone loss rapidly occurs due to menopause and ovariectomy. Osteoporosis not only causes fractures and severe pain, but also causes bedridden elderly people in particular, so effective treatment is required from the viewpoint of improving the quality of life in an aging society. . Since osteoporosis is difficult to treat after it develops, it is important to try to prevent it, and it is essential to increase bone mass from a young age. It has become deeply recognized that foods that promote formation must be actively consumed. Currently, calcium, magnesium and vitamin D are mainly used as foods for strengthening bones. Casein phosphopeptides that promote absorption of calcium from the intestinal tract have also been used.
骨粗鬆症等の骨疾患の治療薬としては、活性型ビタミンD3や女性ホルモン(エストロゲン)、カルシトニン、イプリフラボン類が臨床に用いられ、最近になって、ビタミンK2に代表されるポリイソプレノイド誘導体の破骨細胞形成抑制作用に基づく抗骨粗鬆症剤(例えば、特許文献10参照)も開発されている。また、カゼインホスホペプチド及びゲニステインを有効成分として含有する骨強化剤(例えば、特許文献11参照)、サポニン、ダイジン、ダイゼイン、ゲニスチン及びゲニスティンを主たる有効成分とする骨形成促進及び抗骨粗鬆症組成物(例えば、特許文献12参照)、ワサビ抽出物を有効成分とし、抗骨粗鬆症作用を発揮する骨量増進組成物(例えば、特許文献13参照)、アセキサム酸亜鉛を有効成分とする骨疾患治療剤(例えば、特許文献14参照)、イソフラボンを主たる有効成分とする骨形成促進及び骨塩量減少防止用組成物(例えば、特許文献15参照)、ビタミンK2と亜鉛を共に強化した抗骨粗鬆症組成物(例えば、特許文献16参照)、骨組織復元システムであって、骨格および、骨形成の増進を促進させるために前記骨格に固定させた生物学的活性分子からなる第1成分、ならびに骨再吸収の低減を促進させるための第2成分を含むシステム(例えば、特許文献17参照)なども提案されている。 As therapeutic agents for bone diseases such as osteoporosis, active vitamin D3, female hormone (estrogen), calcitonin, and ipriflavones are used clinically. Recently, osteoclasts of polyisoprenoid derivatives represented by vitamin K2 are used. An anti-osteoporosis agent (for example, see Patent Document 10) based on a formation inhibitory action has also been developed. Further, a bone strengthening and anti-osteoporosis composition comprising, as main active ingredients, a bone strengthening agent containing casein phosphopeptide and genistein as active ingredients (for example, refer to Patent Document 11), saponin, daidzin, daidzein, genistin and genistein (for example, , Refer to Patent Document 12), a bone mass promoting composition containing horseradish extract as an active ingredient and exhibiting an anti-osteoporosis effect (for example, refer to Patent Document 13), and a bone disease therapeutic agent containing zinc acetamate as an active ingredient (for example, Patent Document 14), a composition for promoting bone formation and preventing bone mineral loss (for example, Patent Document 15) containing isoflavone as a main active ingredient, and an anti-osteoporosis composition fortified with both vitamin K2 and zinc (for example, Patent Reference 16), a bone tissue restoration system, in order to promote skeletal and bone formation enhancement The first component consists of biologically active molecules is fixed to the framework and a system including a second component to promote the reduction of bone resorption (e.g., see Patent Document 17) it has been proposed like.
一方、焙煎したおから及び焙煎した大豆胚芽混合物を骨量の増進が必要とされる疾病の予防や治療のために用いられることは知られていなかった。 On the other hand, it has not been known that roasted okara and roasted soybean germ mixture can be used for prevention and treatment of diseases that require bone mass enhancement.
本発明の課題は、天然物であって、安価な原料を加工することによって得られる風味良好な組成物を用いて、積極的に骨形成を促進して、発育期にあるヒトの骨部の形成を助長する骨量増進組成物及び該組成物を含有する機能性食品を提供することにある。 An object of the present invention is to use a composition with good flavor obtained by processing an inexpensive raw material, and actively promote bone formation, so that human bones in the developmental stage An object of the present invention is to provide a bone mass enhancing composition that promotes formation and a functional food containing the composition.
本発明者らは、豆腐の製造の際産出されるおからは、種々の栄養素、生理活性物質を含んでいるにも拘わらず、特有の臭い、味の点で殆どが飼料に利用されるか廃棄されている現状を鑑みて、おからの有効利用を目的とし、特に人の健康の維持、若しくは病気の予防・治療等に新しい効能があるのではないかと種々検討したところ、焙煎したおからとさらに別に焙煎した大豆胚芽との混合物に、顕著な骨量増進作用があることを見い出した。すなわち、焙煎おからと焙煎大豆胚芽との混合物を含む水溶液を成長期及び加齢期のラットに1日1回7日間経口投与した短期間の摂取によるラット大腿骨の骨幹部(皮質量)及び骨幹端部(海綿骨)組織における骨成分の変動からみて、焙煎おからと焙煎大豆胚芽との混合物抽出液(1.0ml/100g体重)の投与により、骨カルシウム量の有意な増加が引き起こされた。一方、焙煎おから抽出液単独より焙煎おからと焙煎大豆胚芽との混合物が骨増進効果が認められた。このような焙煎おからと焙煎大豆胚芽が骨成分増加効果を奏するとの知見は現在まで報告されていない。また、ラットにおける骨形成量の増大が確認された効果は、経験的にヒトでもほぼ100%有効性が確認されている。本発明はこれら知見に基づいて完成するに至ったものである。 The present inventors have found that okara produced during the production of tofu is mostly used for feed in terms of its characteristic odor and taste despite containing various nutrients and physiologically active substances. In light of the current state of being discarded, the purpose of effective utilization from okara has been variously examined for the maintenance of human health or the prevention and treatment of diseases. It has been found that a mixture with roasted soybean germs has a remarkable bone mass promoting effect. That is, the femoral diaphysis (skin mass) of a rat femur obtained by short-term ingestion of an aqueous solution containing a mixture of roasted okara and roasted soybean germ once a day for 7 days to growing and aging rats ) And changes in bone components in the metaphyseal (cancellous bone) tissue, the administration of a mixture extract of roasted okara and roasted soybean germ (1.0 ml / 100 g body weight) significantly increased the amount of bone calcium. An increase was caused. On the other hand, a mixture of roasted okara and roasted soybean germ was recognized to have a bone promoting effect than roasted okara extract alone. The knowledge that such roasted okara and roasted soybean germ have an effect of increasing bone components has not been reported so far. In addition, the effect of confirming an increase in bone formation in rats has been empirically confirmed to be almost 100% effective in humans. The present invention has been completed based on these findings.
すなわち本発明は、焙煎したおから若しくはその処理物と、焙煎した大豆胚芽若しくはその処理物との混合物、又はその処理物を有効成分とすることを特徴とする骨量増進組成物(請求項1)や、焙煎したおからと焙煎した大豆胚芽とが7:3〜9:1の割合で混合されていることを特徴とする請求項1記載の骨量増進組成物(請求項2)や、焙煎したおからが、おからを280℃〜320℃で熱風乾燥し、得られた乾燥おからを220℃〜260℃でドラム乾燥し、強制冷却することにより得られたものであることを特徴とする請求項1又は2記載の骨量増進組成物(請求項3)や、焙煎した大豆胚芽が、乾燥大豆を脱皮・脱胚芽処理し、選別機により、皮・胚芽を分離し、風力又はロールによる選別機により胚芽を分離し、220〜260℃でドラム乾燥することにより得られたものであることを特徴とする請求項1〜3のいずれか記載の骨量増進組成物(請求項4)に関する。 That is, the present invention provides a bone mass enhancing composition characterized by comprising a mixture of roasted okara or its processed product and roasted soybean germ or its processed product, or a processed product thereof as an active ingredient (claim) Item 1), or roasted okara and roasted soybean germ are mixed in a ratio of 7: 3 to 9: 1. 2) or roasted okara obtained by drying the okara in hot air at 280 ° C to 320 ° C, drying the resulting dried okara at 220 ° C to 260 ° C and forcibly cooling it The bone mass enhancing composition according to claim 1 or 2 (claim 3) or the roasted soybean germ is processed by molting and de-embrying the dried soybean, And the germs are separated by a wind or roll sorter, 220-26 ℃ in bone enhancing composition according to any one of claims 1 to 3, characterized in that is obtained by drum drying about (claim 4).
また本発明は、焙煎したおから若しくはその処理物と、焙煎した大豆胚芽若しくはその処理物との混合物、又はその処理物を含有する飲食品であって、骨量増進作用を有することを特徴とする骨量の増進が必要とされる疾病の予防・治療用の機能性食品(請求項5)や、焙煎したおから若しくはその処理物と、焙煎した大豆胚芽若しくはその処理物との混合物、又はその処理物を含有する飲食品であって、骨量増進作用を有することを特徴とし、骨量の増進が必要とされる疾病の予防・治療のために用いられる旨の表示を付した機能性食品(請求項6)や、焙煎したおからと焙煎した大豆胚芽との混合物が、焙煎したおからと焙煎した大豆胚芽とが7:3〜9:1の割合で混合されたものであることを特徴とする請求項5又は6記載の機能性食品(請求項7)や、焙煎したおからが、おからを280℃〜320℃で熱風乾燥し、得られた乾燥おからを220℃〜260℃でドラム乾燥し、強制冷却することにより得られたものであることを特徴とする請求項5〜7のいずれか記載の機能性食品(請求項8)や、焙煎した大豆胚芽が、乾燥大豆を脱皮・脱胚芽処理し、選別機により、皮・胚芽を分離し、風力又はロールによる選別機により胚芽を分離し、220〜260℃でドラム乾燥することにより得られたものであることを特徴とする請求項5〜7のいずれか記載の機能性食品(請求項9)に関する。 Further, the present invention is a mixture of roasted okara or processed product thereof and roasted soybean germ or processed product thereof, or a food or drink containing the processed product, and has a bone mass promoting action. Functional foods for prevention and treatment of diseases that require increased bone mass (claim 5), roasted okara or processed product thereof, roasted soybean germ or processed product thereof It is a food and drink containing a mixture of the above or a processed product thereof, characterized by having a bone mass promoting action, and a label indicating that it is used for the prevention and treatment of diseases requiring bone mass enhancement The functional food (Claim 6) or the mixture of roasted okara and roasted soybean germ is in a ratio of 7: 3 to 9: 1 between roasted okara and roasted soybean germ. 7. Functionality according to claim 5 or 6, characterized in that it is a mixture of Product (Claim 7) or roasted okara is dried in hot air at 280 ° C to 320 ° C, and the resulting dried okara is drum dried at 220 ° C to 260 ° C and forcedly cooled. A functional food product according to any one of claims 5 to 7 or a roasted soybean germ, which is obtained by subjecting dried soybeans to molting and de-embrying, and a sorter. According to any one of claims 5 to 7, characterized in that it is obtained by separating the skin / germ by using a wind or roll sorter and drum drying at 220 to 260 ° C. It relates to the functional food described in claim 9.
さらに本発明は、飲食品が、飴、ヨーグルト、ドリンクヨーグルト、ジュース、牛乳、豆乳、酒類、コーヒーであることを特徴とする請求項5〜9のいずれか記載の機能性食品(請求項10)や、飲食品が、スポーツ飲料等の各種飲料や、プリン、クッキー、パン、ケーキ、ゼリー、煎餅などの焼き菓子、羊羹などの和菓子、冷菓、チューインガム等のパン・菓子類や、うどん、そば等の麺類や、かまぼこ、ハム、魚肉ソーセージ等の魚肉練り製品や、みそ、しょう油、ドレッシング、マヨネーズ、甘味料等の調味類や、チーズ、バター等の乳製品や、豆腐、こんにゃく、その他佃煮、餃子、コロッケ、サラダであることを特徴とする請求項5〜9のいずれか記載の機能性食品(請求項11)に関する。 Furthermore, in the present invention, the functional food according to any one of claims 5 to 9, wherein the food or drink is salmon, yogurt, drink yogurt, juice, milk, soy milk, liquor, or coffee (claim 10). And food and drinks such as sports drinks, baked confectionery such as pudding, cookies, bread, cakes, jellies, rice crackers, Japanese confectionery such as yokan, frozen confectionery, chewing gum and other bread and confectionery, udon and soba Noodles, fish paste products such as kamaboko, ham, fish sausage, seasonings such as miso, soy sauce, dressing, mayonnaise, sweeteners, dairy products such as cheese and butter, tofu, konjac, other boiled fish, dumplings, It is a croquette and a salad, It is related with the functional food (claim 11) in any one of Claims 5-9 characterized by the above-mentioned.
本発明の、焙煎したおから及び焙煎した大豆胚芽との混合物を有効成分とし、積極的に骨量増進をなさしめて骨疾患を予防・治療することができる顕著な効果を有する骨量増進組成物や、該組成物を含有する機能性食品を提供する。 The bone mass enhancement having a remarkable effect that the mixture of roasted okara and roasted soybean germ of the present invention can be used as an active ingredient, and bone mass can be actively promoted to prevent and treat bone diseases. A composition and a functional food containing the composition are provided.
本発明の骨量増進組成物としては、焙煎したおから若しくはその処理物と、焙煎した大豆胚芽若しくはその処理物との混合物、又はその処理物を有効成分とする組成物であれば特に制限されるものではなく、上記処理物としては、微粉砕物、顆粒化物、懸濁物、抽出物、酵素処理物、発酵処理物、冷凍物などを例示することができる。 The bone mass enhancing composition of the present invention is a mixture of roasted okara or processed product thereof and roasted soybean germ or processed product thereof, or a composition containing the processed product as an active ingredient. The treated product is not limited, and examples of the treated product include a finely pulverized product, a granulated product, a suspension, an extract, an enzyme-treated product, a fermented product, and a frozen product.
本発明で使用する焙煎おからと焙煎大豆胚芽とを骨量増進組成物として用いるためには、おから及び大豆胚芽はそれぞれ物性等が異なり、最大の骨量増進効果と最適の味や風味を得るために、それぞれを別々に焙煎する必要がある。焙煎処理は、これらの食品に香ばしさを与え、大豆臭を消して食味や風味を倍加させる。また、焦げ色を付けることで視覚的にも風味を倍加させることができる。 In order to use the roasted okara and roasted soybean germ used in the present invention as the bone mass enhancing composition, the okara and soybean germ have different physical properties, etc., and the maximum bone mass enhancing effect and optimal taste and Each must be roasted separately to obtain a flavor. The roasting treatment adds flavor to these foods, eliminates the soy odor, and doubles the taste and flavor. In addition, the flavor can be doubled visually by adding a burnt color.
本発明において、焙煎おからと焙煎大豆胚芽との配合比率(重量)は、特に制限されるものではないが、7:3〜9:1の割合で混合されることが好ましい。 In the present invention, the blending ratio (weight) of roasted okara and roasted soybean germ is not particularly limited, but is preferably mixed at a ratio of 7: 3 to 9: 1.
焙煎胚芽が混合物の10%以上であると、骨量増進の作用が十分に発揮することができ、また30%以下では、骨量増進作用に優れ、供給源が少ない焙煎大豆胚芽を有効に利用でき、焙煎おからとの相乗作用も期待できる。 When the roasted germ is 10% or more of the mixture, the effect of promoting bone mass can be fully exerted. When the roasted germ is 30% or less, roasted soybean germ having excellent bone mass promoting effect and less supply source is effective. It can also be used for synergy with roasted okara.
本発明の焙煎大豆胚芽を添加した焙煎おからの製造方法について、図1により説明する。先ず、本発明で使用する焙煎おからの原料である生おからは、通常、豆腐を製造するときの豆乳の絞り粕であるおからであれば特に制限されるものではない。おからは、通常、水分約80〜85%を含んでおり、このように水分を多量に含んでいるので、先ず、熱風乾燥などの乾燥手段により水分5〜10%になるまで乾燥する乾燥工程(乾燥おから)に入る。乾燥工程では、熱風乾燥の他に、ドラム乾燥、マイクロ波照射による乾燥、ローラー式加熱乾燥等が採用できるが、本発明では特に熱風乾燥が好ましい。乾燥温度、乾燥時間は、乾燥法の種類により異なるが、熱風乾燥を採用する場合は、280℃〜320℃の温度で、重量が約1/5程度になるまで乾燥を行う。乾燥後の水分5〜10%を含むおからを焙煎工程(焙煎おから)に移す。本発明における焙煎方法は特に制限されるものではないが、焙煎工程では、ドラム式焙煎、焙煎釜への直接加熱による焙煎、オーブン内での雰囲気加熱による焙煎等があるが、適宜これらの焙煎方法を採用できる。本発明では、ドラム式焙煎が好ましく、220〜260℃の温度で行い、焙煎時間は、おから特有の臭みが取れ、かつ焦げ臭のない程度の時間で焙煎することが好ましい。 A method for producing roasted okara added with the roasted soybean germ of the present invention will be described with reference to FIG. First, raw okara, which is a raw material from roasted okara used in the present invention, is not particularly limited as long as it is okara that is a squeezed koji of soy milk when producing tofu. Okara usually contains about 80 to 85% of moisture, and since it contains a large amount of moisture in this way, it is first dried to a moisture content of 5 to 10% by drying means such as hot air drying. Enter (dried okara). In the drying step, in addition to hot air drying, drum drying, drying by microwave irradiation, roller-type heat drying, and the like can be adopted. In the present invention, hot air drying is particularly preferable. Although drying temperature and drying time vary depending on the type of drying method, when hot air drying is employed, drying is performed at a temperature of 280 ° C. to 320 ° C. until the weight reaches about 1/5. Okara containing 5-10% of moisture after drying is transferred to a roasting process (roasted okara). The roasting method in the present invention is not particularly limited, but in the roasting process, there are drum-type roasting, roasting by direct heating to the roasting pot, roasting by heating in the atmosphere in the oven, etc. These roasting methods can be employed as appropriate. In the present invention, drum-type roasting is preferable, and the roasting is preferably performed at a temperature of 220 to 260 ° C. The roasting time is preferably roasted in such a time that a characteristic odor is removed and there is no burning odor.
本発明で使用する大豆胚芽は、大豆の種類には特に制限されず、大豆胚芽であればよく、生の大豆を乾燥工程(乾燥大豆)に付し、次いで共雑物から精選するために選別機により選別して乾燥大豆を得、さらに、乾燥大豆を、回転する複数の羽根と網状のドラムとの相互作用により脱皮、脱胚芽処理を行い、皮、大豆胚芽を得る。その後、皮と大豆胚芽とを分離するために、風力・ロール選別等による選別機を用いて選別して大豆胚芽を得ることができる。該大豆胚芽を焙煎する方法としては、焙煎による焦げ臭が少なく、芳しい風味を有する大豆胚芽が得られる方法であればどのような方法でもよく、例えば、220〜260℃のドラム式焙煎機により焙煎する方法が好ましく、焙煎時間は、前記温度の範囲内で、温度が低いと焙煎時間を長くし、逆に温度が高いと焙煎時間を短かくするなど適宜選択することができる。 The soybean germ used in the present invention is not particularly limited to the kind of soybean, and may be any soybean germ. The soybean is subjected to a drying process (dried soybean) and then selected for selection from congeners. Dry soybeans are obtained by sorting with a machine. Further, the dried soybeans are dehulled and de-embedded by the interaction of a plurality of rotating blades and a net-like drum to obtain skin and soybean germs. Thereafter, in order to separate the skin and soybean germ, the soybean germ can be obtained by sorting using a sorting machine such as wind and roll sorting. As a method for roasting the soy germ, any method may be used as long as the soy germ having a rich flavor is obtained with little burning odor by roasting. For example, drum roasting at 220 to 260 ° C. A method of roasting by a machine is preferred, and the roasting time is appropriately selected within the above temperature range, such as increasing the roasting time if the temperature is low and conversely shortening the roasting time if the temperature is high. Can do.
おからを原料とする工程から得られた焙煎おからと、乾燥大豆を原料とする工程より得られた焙煎胚芽とをミキサー等により適宜の割合でブレンドする。このようにして、焙煎胚芽入りおからを製造することができる。 The roasted okara obtained from the process using okara as a raw material and the roasted germ obtained from the process using dry soybean as a raw material are blended at an appropriate ratio by a mixer or the like. In this way, roasted germ-containing okara can be produced.
上記本発明の骨量増進作用を有する、焙煎おからと焙煎大豆胚芽との混合物を含有する機能性食品又は食品素材は、飲食品原料の一部として用いたり、あるいは製造工程又は製造後に添加・配合することにより得ることができる。かかる機能性食品としては特に制限されるものではなく、ヨーグルト、ドリンクヨーグルト、ジュース、牛乳、豆乳、酒類、コーヒー、紅茶、煎茶、ウーロン茶、スポーツ飲料等の各種飲料や、クッキー、パン、ケーキ、煎餅などの焼き菓子、ラムネ菓子等などの錠菓、羊羹などの和菓子、プリン、ゼリー、アイスクリーム類などの冷菓、チューインガム、飴等の菓子類や、クラッカー、チップス等のスナック類や、うどん、そば等の麺類や、かまぼこ、ハム、魚肉ソーセージ等の魚肉練り製品や、チーズ、バターなどの乳製品や、みそ、しょう油、ドレッシング、マヨネーズ、ふりかけ、甘味料等の調味類や、豆腐、こんにゃく、その他佃煮、餃子、コロッケ、サラダ、スープ、シチュー等の各種総菜などを具体的に例示することができる。例えば、焙煎おからと焙煎大豆胚芽との混合物を微粉末化し、該微粉末を常法に従い打錠することにより錠菓を製造することができ、この場合かかる微粉末を造粒した後に打錠することもできる。好ましくは、前記の微粉末化物を飴の製造過程で混合しておから飴としたり、ふりかけの一原料としておからふりかけとしたり、冷菓の材料に用いておからアイス飲料とすることができる。また、チューインガムに用いておからガムとしたり、各種シリアルに混合しておからシリアルとすることができる。さらに、おからには、食物繊維が多く含まれており、本発明の混合物にも同様に食物繊維を多く含有していることから、おからファイバーとして各種食品及び飲料等に混入することができる。 The functional food or food material containing the mixture of roasted okara and roasted soybean germ having the bone mass promoting effect of the present invention is used as a part of the raw material for food and drink, or after the production process or production It can be obtained by adding and blending. Such functional food is not particularly limited, and various drinks such as yogurt, drink yogurt, juice, milk, soy milk, alcoholic beverages, coffee, tea, sencha, oolong tea, sports drinks, cookies, bread, cakes, rice crackers Baked confectionery such as confectionery such as ramune confectionery, Japanese confectionery such as mutton, frozen confectionery such as pudding, jelly and ice cream, confectionery such as chewing gum and candy, snacks such as crackers and chips, udon and soba Noodles such as kamaboko, ham, fish sausage, etc., dairy products such as cheese, butter, miso, soy sauce, dressing, mayonnaise, sprinkles, sweeteners, etc., tofu, konjac Specific examples include various side dishes such as dumplings, croquettes, salads, soups, stews, etc.For example, a mixture of roasted okara and roasted soybean germ can be made into a fine powder, and the fine powder can be tableted according to a conventional method to produce a tablet confection. In this case, after granulating such a fine powder Tableting is also possible. Preferably, the finely powdered product can be mixed in the manufacturing process of the koji, then used as koji, used as a raw material for koji, or used as a frozen confectionery material for an iced beverage. Moreover, it can be used for chewing gum to make okara gum, or it can be mixed with various cereals before making cereals. Furthermore, since okara contains a lot of dietary fiber and the mixture of the present invention also contains a lot of dietary fiber, it can be mixed in various foods and beverages as okara fiber.
(焙煎おからと焙煎大豆胚芽との混合物の製造法)
豆腐の製造時に副産物としてできたおからを熱風チャンバー室において300℃の熱風で当初の重量の約1/5になるまで乾燥した。即ち、水分含量5〜10%まで乾燥し、該乾燥おからを220℃〜260℃の温度においてドラム式の加熱機により焙煎し、強制冷却した。焙煎後の重量は、焙煎前の重量の約5/6程度となった。
(Method for producing a mixture of roasted okara and roasted soybean germ)
Okara produced as a by-product during the production of tofu was dried with hot air at 300 ° C. in a hot air chamber until it became about 1/5 of the original weight. That is, it was dried to a moisture content of 5 to 10%, and the dried okara was roasted with a drum-type heater at a temperature of 220 ° C. to 260 ° C. and forcedly cooled. The weight after roasting was about 5/6 of the weight before roasting.
一方、焙煎大豆胚芽の製造方法は、乾燥大豆を共雑物から精選するために選別機により選別して精選乾燥大豆を得、さらに、精選乾燥大豆を、回転する複数の羽根と網状のドラムとの相互作用により脱皮、脱胚芽処理を行う。その後、種皮と大豆胚芽とを分離するために、風力・ロール選別による選別機を用いて選別して大豆胚芽を得た。該大豆胚芽を220℃〜260℃の温度においてドラム式の加熱機により焙煎し、強制冷却した。焙煎後の重量は、焙煎前の重量の約6/7となった。 On the other hand, in the method for producing roasted soybean germs, in order to select dry soybeans from common substances, they are sorted by a sorting machine to obtain selected dried soybeans. Further, the selected dried soybeans are rotated with a plurality of rotating blades and a net-like drum. Dehulling and de-embrying treatment are performed by interacting with. Then, in order to isolate | separate a seed coat and soybean germ, it isolate | separated using the sorter by a wind force and roll selection, and obtained soybean germ. The soybean germ was roasted with a drum-type heater at a temperature of 220 ° C. to 260 ° C. and forcedly cooled. The weight after roasting was about 6/7 of the weight before roasting.
前記の製造方法により得られた焙煎おからと焙煎大豆胚芽とを、80:20の割合で混合することにより、本発明の焙煎混合物が得られた。 The roasting mixture of the present invention was obtained by mixing the roasted okara obtained by the above production method and the roasted soybean germ in a ratio of 80:20.
粉末状の焙煎おから(100%)及び焙煎おからと焙煎大豆胚芽のそれぞれ100g中の生理活性物質について、日本食品分析センターにより分析されたものを表1に示す。大豆サポニン量については、標準品として、ソヤサポゲノールA及びソヤサポゲノールBを用い、それぞれをソヤサポニンA1及びソヤサポニンIに換算してその合計量を大豆サポニン量とした。 Table 1 shows bioactive substances in 100 g of powdered roasted okara (100%) and roasted okara and roasted soybean germ, which were analyzed by the Japan Food Research Center. As for the amount of soybean saponin, soya saponin A and soya saponin B were used as standard products, and these were converted into soya saponin A 1 and soya saponin I, respectively, and the total amount was taken as the amount of soybean saponin.
表1より、粉末焙煎おから単独よりは、さらに粉末焙煎大豆胚芽を80:20の割合で混合したものが、大豆サポニンでは4倍、ダイジンでは17倍、ダイゼインでは1.35倍、ゲネスチンでは4.55倍増えており、ゲネステインではほぼ等倍である。 According to Table 1, the mixture of powder roasted soybean germs in a ratio of 80:20 is 4 times for soybean saponin, 17 times for daidzin, 1.35 times for daidzein, and 1. Is 4.55 times greater than that of Genestein.
(実験方法)
焙煎おから(100%)或いは焙煎おから(80%)と大豆胚芽(20%)との混合物を用いて、その100gに水1000mlを加え80〜90℃で20分間加熱抽出し、抽出液中に含まれる生理活性成分の含量を日本食品分析センターにより分析された結果を表2,3に示す。
(experimental method)
Using roasted okara (100%) or a mixture of roasted okara (80%) and soybean germ (20%), add 1000 ml of water to 100 g of the mixture and extract by heating at 80-90 ° C. for 20 minutes. Tables 2 and 3 show the results of analysis by the Japan Food Research Center on the content of physiologically active ingredients contained in the liquid.
表2と表3より、熱湯により抽出した、焙煎おからと焙煎大豆胚芽との混合物は焙煎おから単独のものより、大豆サポニンは、4.84倍増加し、検出されなかったダイジン、ゲネスチンは、それぞれ6.1mg/100g、1.0mg/100g含有されていることがわかった。これらの結果は、焙煎大豆胚芽を混合したことによるものと思われる。 From Tables 2 and 3, the mixture of roasted okara and roasted soybean germ extracted with boiling water was higher than that of roasted oat alone, soy saponin increased 4.84 times and was not detected Genestin was found to be 6.1 mg / 100 g and 1.0 mg / 100 g, respectively. These results are likely due to the mixing of roasted soybean germ.
前記の焙煎おから、及び焙煎おからと焙煎大豆胚芽との混合物の加熱抽出液を用いて、その1.0mlをラットに1日1回7日間胃ゾンデを用いて経口投与し、最終投与の24時間目に軽いエーテル麻酔下で、心臓せん刺により採血後、解剖し、大腿骨を抽出した。使用したラットは、日本エスエルシー(浜松)より入手し、体重90〜100gの4週齢の雄ラットを用いた。一方、骨粗鬆症との関連で雌性の加齢(50週齢)ラットも使用した。 Using the above-mentioned roasted okara and a heated extract of a mixture of roasted okara and roasted soybean germ, 1.0 ml thereof was orally administered to a rat once a day using a gastric sonde, At 24 hours after the final administration, blood was collected by cardiac puncture under light ether anesthesia, followed by dissection and extraction of the femur. The rats used were obtained from Nippon SLC (Hamamatsu), and 4-week-old male rats weighing 90-100 g were used. Meanwhile, female aged (50 weeks old) rats were also used in the context of osteoporosis.
採血した血液は2000回転で5分間遠心分離し、その上澄(血清)を採取し、カルシウム及び無機リン濃度を測定した。 The collected blood was centrifuged at 2000 rpm for 5 minutes, the supernatant (serum) was collected, and the calcium and inorganic phosphorus concentrations were measured.
大腿骨は、筋肉を取り除き、骨髄を冷0.25M蔗糖液中で洗浄除去し、骨幹部(皮質骨)と骨幹端部(海綿骨)に分け、そのカルシウム量、骨石灰化促進酵素のアルカリ性ホスファターゼ活性及び骨組織中の細胞数の指標としてのDNA量を測定するために使用した。 The femur removes muscles, and the bone marrow is washed and removed in cold 0.25M sucrose solution, divided into a diaphysis (cortical bone) and a metaphysis (cancellous bone), and its calcium content and alkalinity of bone mineralization promoting enzyme Used to measure the amount of DNA as an indicator of phosphatase activity and the number of cells in bone tissue.
得られた結果は、Student’st検定を用いて統計的に処理し、危険率0.05以下の場合に有意差があるとした。 The obtained results were statistically processed using the Student'st test, and it was assumed that there was a significant difference when the risk rate was 0.05 or less.
(骨カルシウムの測定)
組織片に濃硝酸を加えて120℃で12時間灰化し、原子吸光分光光度計(パーキンエルマー社製「パーキンエルマー303」)を用いて骨カルシウム量を定量した。
(Measurement of bone calcium)
Concentrated nitric acid was added to the tissue pieces to make them incinerate at 120 ° C. for 12 hours, and the amount of bone calcium was quantified using an atomic absorption spectrophotometer (“Perkin Elmer 303” manufactured by Perkin Elmer).
(アルカリ性ホスファターゼ活性の測定)
骨の石灰化の促進に関する最も重要な酵素であるアルカリ性ホスファターゼの量を調べた。骨組織片を0.25Mの蔗糖液で洗浄し、6.5mMのバルビタール緩衝液(pH7.4)3ml中で破砕し、超音波処理した。この液を遠心分離して上清を酵素液としてWalter及びSchuttの方法(in Method of Enzymatic Analysis, Vol1-2,p856, Academic Press, New York, 1965)に従って測定した。すなわち、p−ニトロフェニール燐酸を基質として、ジエタノールアミン緩衝液(pH9.8)2mlに酵素液0.05mlを添加し、37℃で30分間インキュベーションし、0.05NのNaOHを10ml添加した後、分光光度計を用いて吸光度(405nm)を測定し、骨に対する治療剤及び骨に対する作用の知られている化合物の骨アルカリ性ホスファターゼ活性を調べた。
(Measurement of alkaline phosphatase activity)
The amount of alkaline phosphatase, the most important enzyme for promoting bone mineralization, was investigated. Bone tissue pieces were washed with 0.25 M sucrose solution, crushed in 3 ml of 6.5 mM barbital buffer (pH 7.4), and sonicated. This solution was centrifuged, and the supernatant was measured as an enzyme solution according to the method of Walter and Schutt (in Method of Enzymatic Analysis, Vol1-2, p856, Academic Press, New York, 1965). Specifically, 0.05 ml of enzyme solution was added to 2 ml of diethanolamine buffer (pH 9.8) using p-nitrophenyl phosphate as a substrate, incubated at 37 ° C. for 30 minutes, and 10 ml of 0.05N NaOH was added. Absorbance (405 nm) was measured using a photometer, and the bone alkaline phosphatase activity of a therapeutic agent for bone and a compound known to act on bone was examined.
(DNA量の定量)
骨組織片を0.25Mの蔗糖溶液で洗浄し、湿重量を測定した。その後、0.1NのNaOH4ml中で粉砕して、4℃で24時間浸透させた。この液を遠心分離し、上清を試料としてCeriottiらの方法(J.Biol.Chem., 241: 34-77, 1951)に従って定量した。即ち、試料2mlに濃塩酸1ml及び0.04%のインドール溶液1mlを添加し沸騰水中で100℃に加熱後、急冷して、クロロホルム4mlで抽出し、クロロホルム層を採取して、分光光度計(490nm)を用いて骨中のDNA量を測定した。
(Quantification of DNA content)
The bone tissue piece was washed with a 0.25M sucrose solution and the wet weight was measured. Then, it grind | pulverized in 4 ml of 0.1N NaOH, and it was made to osmose | permeate at 4 degreeC for 24 hours. This solution was centrifuged, and the supernatant was used as a sample for quantification according to the method of Ceriotti et al. (J. Biol. Chem., 241: 34-77, 1951). That is, 1 ml of concentrated hydrochloric acid and 1 ml of 0.04% indole solution were added to 2 ml of sample, heated to 100 ° C. in boiling water, rapidly cooled, extracted with 4 ml of chloroform, the chloroform layer was collected, and a spectrophotometer ( 490 nm) was used to measure the amount of DNA in the bone.
(成長期ラットに及ぼす効果について)
成長期(雄性、5週齢)のラットに焙煎おから、及び焙煎おからと焙煎大豆胚芽との混合物をそれぞれ加熱抽出した溶液をラット体重100g当たり、1.0mlを1日1回7日間連続経口投与した。ときの血清成分と骨成分の変動を調べた。その結果を表4及び表5に示す。
(Effects on growing rats)
Growth solution (male, 5 weeks old) of rat roasted oat and a mixture of roasted okara and roasted soybean germ heated and extracted 1.0 ml per 100 g rat weight once a day Oral administration was continued for 7 days. Changes in serum and bone components were examined. The results are shown in Tables 4 and 5.
前記表4によると、焙煎おから、及び焙煎おからと焙煎大豆胚芽との混合物の抽出液の投与は、ラットの体重並びに血清中カルシウムと無機リン濃度の有意な変動を引き起こさなかったことから、毒性的効果を示さなかった。 According to Table 4 above, administration of the extract of roast okara and a mixture of roast okara and roasted soybean germ did not cause significant changes in rat body weight and serum calcium and inorganic phosphorus concentrations. Therefore, it did not show a toxic effect.
ラットの大腿骨組織を骨幹部(皮質骨)と骨幹端部(海綿骨)組織に分け、それぞれの骨成分の変動を調べた。その結果、表5に示すように、骨幹部及び骨幹端部組織のカルシウム量は、焙煎おから、及び焙煎おからと焙煎大豆胚芽との混合物の抽出物の投与のいずれも有意に増加することが分った。骨幹部カルシウム量の増加は、焙煎おから抽出液よりも焙煎おからと焙煎大豆胚芽との混合物の抽出液を投与した場合において、強い効果が認められた。 Rat femur tissue was divided into diaphyseal (cortical bone) and metaphyseal (cancellous) tissues, and the changes in each bone component were examined. As a result, as shown in Table 5, the amount of calcium in the diaphyseal part and metaphyseal part tissue was significantly increased in both roasted oat and administration of the extract of the roasted oat and roasted soybean germ mixture. It has been found to increase. The increase in the amount of calcium in the diaphysis was stronger when the extract of the mixture of roasted okara and roasted soybean germ was administered than the roasted oat extract.
骨組織中のアルカリ性ホスファターゼは骨石灰化促進酵素として機能し、造骨細胞の骨芽細胞のマーカー酵素である。骨幹部及び骨幹端部組織のアルカリ性ホスファターゼ活性は、焙煎おから、及び焙煎おからと焙煎大豆胚芽との混合物の抽出液の投与により、有意に増加したが、焙煎大豆胚芽添加の効果は見られなかった。 Alkaline phosphatase in bone tissue functions as a bone mineralization-promoting enzyme and is a marker enzyme for osteoblasts of osteoblasts. Alkaline phosphatase activity in the diaphyseal and metaphyseal tissues was significantly increased by administration of the extract from roasted oats and a mixture of roasted oats and roasted soy germs, but with the addition of roasted soy germs No effect was seen.
骨組織中のDNA量は、骨組織中の細胞数の指標となり得る。骨幹部組織中のDNA量は焙煎おから抽出液の投与で有意に増加しなかったが、焙煎おからと焙煎大豆胚芽との混合物の抽出液を投与した場合には有意に増大することが見出され、焙煎大豆胚芽添加の効果が認められた。 The amount of DNA in bone tissue can be an indicator of the number of cells in bone tissue. The amount of DNA in the diaphyseal tissue did not increase significantly with the administration of roasted okara extract, but increased significantly when the extract of the mixture of roasted okara and roasted soybean germ was administered. As a result, the effect of adding roasted soybean germ was recognized.
骨幹端部組織中のDNAは、焙煎おから抽出液、及び焙煎おからと焙煎大豆胚芽との混合物の抽出液の投与により有意に増加した。 The DNA in the metaphyseal tissue was significantly increased by administration of roast okara extract and a mixture of roast okara and roasted soybean germ.
(加齢期ラットに及ぼす効果について)
雌性の加齢期(50週齢)のラットを閉経後骨粗鬆症に対するモデル動物として用いた。焙煎おから抽出液、及び焙煎おからと焙煎大豆胚芽との混合物の抽出液をラット体重100g当たり1.0mlを1日1回7日間経口投与した。その最終投与の24時間目に軽いエーテル麻酔下で解剖した。ラットの体重、血清中カルシウム及び無機リン濃度を測定した。その結果を表6に示す。
(Effects on aging rats)
Female aging (50 weeks old) rats were used as model animals for postmenopausal osteoporosis. An extract of roasted okara extract and a mixture of roasted okara and roasted soybean germ was orally administered at a rate of 1.0 ml per 100 g of rat body weight once a day for 7 days. Dissection was performed under light ether anesthesia 24 hours after the final administration. Rat body weight, serum calcium and inorganic phosphorus concentrations were measured. The results are shown in Table 6.
表6より、焙煎おから抽出液、及び焙煎おからと焙煎大豆胚芽との混合物の抽出液を投与したものとでは、ラットの体重、血清中のカルシウム及び無機リン濃度のいずれも有意に変動しなかった。 Table 6 shows that rat body weight, serum calcium and inorganic phosphorous concentrations are all significant when roasted okara extract and the mixture of roasted okara and roasted soybean germ are administered. It did not fluctuate.
次に大腿骨組織の骨成分の変動を調べた。その結果を表7に示す。 Next, the variation of the bone component of the femoral tissue was examined. The results are shown in Table 7.
表7より、骨幹部及び骨幹端部組織中のカルシウム量は、焙煎おから抽出液、及び焙煎おからと焙煎大豆胚芽との混合物の抽出液を投与したものでは有意に増加したが、その効果は焙煎大豆胚芽を添加した焙煎おから抽出液の方が強かった。 一方、骨幹部及び骨幹端部組織中のアルカリホスファターゼ及びDNA量は、焙煎おから抽出液を投与したものでは有意に増加しなかったが、焙煎おからと焙煎大豆胚芽との混合物の抽出液を投与したものでは有意に増大することが見出された。 From Table 7, although the amount of calcium in the diaphysis and metaphyseal tissue was significantly increased in the case of administering the roast okara extract and the mixture of roast okara and roasted soybean germ. The effect of roasted okara to which roasted soybean germ was added was stronger. On the other hand, the amount of alkaline phosphatase and DNA in the diaphysis and metaphyseal tissue did not increase significantly when the extract was administered from roasted oat, but the amount of the mixture of roasted okara and roasted soybean germ It was found that the dose of the extract was significantly increased.
このように、実施例3,4において、焙煎おから、及び焙煎おからと焙煎大豆胚芽との混合物のそれぞれの抽出液をラットに経口投与して、その骨成分に及ぼす効果を調べた。その結果、焙煎おから抽出液をラットに7日間経口投与すると骨成分が増加する効果がもたらされることが見出された。さらに焙煎おからと焙煎大豆胚芽との混合物の抽出液を投与したものでは、その効果は有意に増進することがわかった。焙煎おから、及び焙煎おからと焙煎大豆胚芽との混合物の両抽出液中において、前記の表2(焙煎おから100%)と表3(焙煎おから80%と焙煎大豆胚芽20%)を比較すると、表2には、大豆サポニンが含有され、イソフラボンは検出されず、表3には、大豆サポニンの濃度が極めて高く、イソフラボン(ダイジン、ゲネステイン)も含有されていることから、サポニン投与が骨成分の増量を引き起こすことがラットを用いた実験により明らかとなった。したがって、焙煎おからの骨成分増加効果は、主にサポニンによるものであり、焙煎大豆胚芽を添加することによりイソフラボンの増加がもたらされ、さらにサポニンの量が増加することから、これらの成分の増量が焙煎おからの抽出液と比較して、焙煎大豆胚芽の抽出液投与の骨成分増進効果として発揮されたものと思われる。 As described above, in Examples 3 and 4, each extract of roasted okara and a mixture of roasted okara and roasted soybean germ was orally administered to rats, and the effect on the bone component was examined. It was. As a result, it was found that when the extract from roasted oat was orally administered to rats for 7 days, the effect of increasing bone components was brought about. Furthermore, it was found that the effect was significantly enhanced in the case of administering an extract of a mixture of roasted okara and roasted soybean germ. In both extracts of roasted okara and a mixture of roasted okara and roasted soybean germ, Table 2 (100% roasted okara) and Table 3 (80% roasted okara and roasted roast) Table 2 contains soy saponin, no isoflavone is detected, and Table 3 contains soy saponin at a very high concentration and also contains isoflavone (Daidin, Genestein). From the above, it was clarified by an experiment using rats that administration of saponin causes an increase in bone component. Therefore, the bone component increase effect from roasted oats is mainly due to saponin, and the addition of roasted soybean germ results in an increase in isoflavones and further increases the amount of saponin. It seems that the increase of the component was demonstrated as the bone component promotion effect of the administration of the roasted soybean germ extract compared to the extract from the roasted oat.
以上のことより、焙煎おから抽出液は骨成分増加効果を奏することが、さらに、本発明の焙煎おからと焙煎大豆胚芽との混合物の抽出液はより強い骨効果をもたらすことが分った。同様に、粉末状の焙煎おからと焙煎大豆胚芽との混合物も、抽出液と同等かそれ以上の骨成分増進効果を奏する。 From the above, the roasted okara extract has the effect of increasing the bone component, and the extract of the mixture of roasted okara and roasted soybean germ of the present invention has a stronger bone effect. I understand. Similarly, a mixture of powdered roasted okara and roasted soybean germ has an effect of promoting bone components that is equal to or higher than that of the extract.
(おから入り飴)
砂糖64g、水アメ29gに水20gを加え混合し、150℃まで煮詰め、水分を完全に蒸発させた後、70℃程度まで冷却し焙煎大豆胚芽5g,焙煎おから10gを添加、混合した後、5gを20mmφの型に入れて整形、冷却して、飴を得た。
(Okara entered bowl)
20 g of water was added to and mixed with 64 g of sugar and 29 g of water candy, boiled to 150 ° C., the water was completely evaporated, then cooled to about 70 ° C., and 5 g of roasted soybean germ and 10 g of roasted rice were added and mixed. After that, 5 g was put into a 20 mmφ mold, shaped and cooled to obtain a bag.
(おから入りアイス飲料)
混合ミキサーに生乳6部、脱脂粉乳5部、バター10部、卵黄3部、グラニュー糖14部、前記実験方法により得られた本発明の焙煎おから混合物抽出液(焙煎大豆胚芽20%含有)10部及び水52部を添加、混合し、30〜50℃に加温しながら粉体物を溶解し、アイスクリームミックスを調製した。このアイスクリームミックスを均質機を用いて均質圧150kg/cm2で均質処理し、次いで90℃で10分間バッチ式殺菌機を用いて加熱殺菌し、プレート式熱交換機を用いて10℃に冷却した。120mlの容器に充填し、アイス飲料を製造した。
(Okara drink with okara)
6 parts raw milk, 5 parts skim milk powder, 10 parts butter, 3 parts egg yolk, 14 parts granulated sugar in a mixing mixer, roasted okara mixture extract obtained by the above experimental method (containing 20% roasted soybean germ) ) 10 parts and 52 parts of water were added and mixed, and the powder was dissolved while heating to 30-50 ° C. to prepare an ice cream mix. The ice cream mix was homogenized using a homogenizer at a homogeneous pressure of 150 kg / cm 2 , then heat sterilized using a batch sterilizer at 90 ° C. for 10 minutes, and cooled to 10 ° C. using a plate heat exchanger. . An iced beverage was produced by filling a 120 ml container.
(おから入りカレールー)
食用油脂32重量部、小麦粉30重量部、本発明の焙煎おから混合物(焙煎大豆胚芽20%含有)粉末6部、カレー粉9部、食塩11部、砂糖4部、調味料(粉末)1.5部、調味料(ペースト)6.5部、乳化剤0.3部を用いて、常法によりカレールーを製造した。
(Okara-entered carrail)
Edible fats and oils 32 parts by weight, wheat flour 30 parts by weight, roasted okara mixture of the present invention (containing roasted soybean germ 20%) powder 6 parts, curry powder 9 parts, salt 11 parts, sugar 4 parts, seasoning (powder) Carreru was produced by a conventional method using 1.5 parts, 6.5 parts of seasoning (paste), and 0.3 part of emulsifier.
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004247411A JP4486447B2 (en) | 2004-08-26 | 2004-08-26 | Bone component increasing composition from soybeans containing soybean germ and functional food containing the composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004247411A JP4486447B2 (en) | 2004-08-26 | 2004-08-26 | Bone component increasing composition from soybeans containing soybean germ and functional food containing the composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2006067801A true JP2006067801A (en) | 2006-03-16 |
JP4486447B2 JP4486447B2 (en) | 2010-06-23 |
Family
ID=36149069
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004247411A Active JP4486447B2 (en) | 2004-08-26 | 2004-08-26 | Bone component increasing composition from soybeans containing soybean germ and functional food containing the composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4486447B2 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101240045B1 (en) * | 2005-04-15 | 2013-03-06 | 대상에프앤에프 주식회사 | A manufacturing method of soybean milk and bean-curd comprising soybean embryo |
JP2013158267A (en) * | 2012-02-02 | 2013-08-19 | Otoufu Factory Ishikawa Co Ltd | Method for producing paste using food residue |
CN103478201A (en) * | 2013-09-15 | 2014-01-01 | 陶峰 | High-calcium red rice cookie |
JP2015139394A (en) * | 2014-01-28 | 2015-08-03 | ミナミ産業株式会社 | Method for manufacturing whole grain soybean beverage |
CN106258061A (en) * | 2016-07-27 | 2017-01-04 | 惠州市黑娜尔科技有限公司 | The sowing pre-treating method of pea seed |
JP6125127B1 (en) * | 2017-01-25 | 2017-05-10 | 久保商事株式会社 | Roasted okara added miso |
JP2018117642A (en) * | 2018-05-09 | 2018-08-02 | ミナミ産業株式会社 | Method for manufacturing whole grain soybean beverage |
-
2004
- 2004-08-26 JP JP2004247411A patent/JP4486447B2/en active Active
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101240045B1 (en) * | 2005-04-15 | 2013-03-06 | 대상에프앤에프 주식회사 | A manufacturing method of soybean milk and bean-curd comprising soybean embryo |
JP2013158267A (en) * | 2012-02-02 | 2013-08-19 | Otoufu Factory Ishikawa Co Ltd | Method for producing paste using food residue |
CN103478201A (en) * | 2013-09-15 | 2014-01-01 | 陶峰 | High-calcium red rice cookie |
JP2015139394A (en) * | 2014-01-28 | 2015-08-03 | ミナミ産業株式会社 | Method for manufacturing whole grain soybean beverage |
CN106258061A (en) * | 2016-07-27 | 2017-01-04 | 惠州市黑娜尔科技有限公司 | The sowing pre-treating method of pea seed |
JP6125127B1 (en) * | 2017-01-25 | 2017-05-10 | 久保商事株式会社 | Roasted okara added miso |
JP2018117574A (en) * | 2017-01-25 | 2018-08-02 | 久保商事株式会社 | Roasted tofu refuse-added miso |
JP2018117642A (en) * | 2018-05-09 | 2018-08-02 | ミナミ産業株式会社 | Method for manufacturing whole grain soybean beverage |
Also Published As
Publication number | Publication date |
---|---|
JP4486447B2 (en) | 2010-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sęczyk et al. | Soymilk enriched with green coffee phenolics–Antioxidant and nutritional properties in the light of phenolics-food matrix interactions | |
JP4480173B2 (en) | Oat granule with high concentration of β-glucan | |
JP2006246795A (en) | Soybean processed product improved in functionality | |
CN110122744A (en) | A kind of quinoa nutrient powder and preparation method thereof | |
Kant | THE THESIS | |
JP3232718B2 (en) | Easy-absorbable mineral-containing composition and food and drink containing it | |
EP0605757A1 (en) | Compositions and goods containing minerals and poly-gamma-glutamic acid | |
JP4486447B2 (en) | Bone component increasing composition from soybeans containing soybean germ and functional food containing the composition | |
RU2456826C2 (en) | Method for production of protein-vitamin-mineral concentrate | |
KR20010104965A (en) | Foods made from seaweeds | |
KR101018923B1 (en) | Soybean-curd babaroa and soybean milk pudding with oligosaccharide and without off-flavor and manufacturing method thereof | |
RU2296473C1 (en) | Method for preparing of food product from bean | |
FI120901B (en) | Functional food and its use | |
JP3551149B2 (en) | Easy-absorbable mineral-containing composition and food and drink containing it | |
JP2010173962A (en) | Glycolytic enzyme inhibitor derived from wheat endosperm and cholesterol-lowering composition containing dietary fiber | |
AU2006347421A1 (en) | Composition for improving skin condition | |
JP3430940B2 (en) | Foods and beverages combining isoflavones and peptides | |
FI115192B (en) | Functional food and process for making this | |
JP6301939B2 (en) | Novel raw materials for functional foods and methods for their preparation | |
US20040265426A1 (en) | Process for producing miso | |
JP4636596B2 (en) | Cereal processed food and its secondary processed food | |
CN101669619A (en) | Method for preparing sweet-potato egg catsup | |
JP2004292382A (en) | Agent for promoting absorption of mineral, and agent for preventing and/or ameliorating osteoporosis | |
JPH0523134A (en) | Promoter for enhancing bone strength and foods containing the same | |
KR102628560B1 (en) | Protein-fortified noodle using chicken breast and manufacturing method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070817 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20090129 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090203 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090401 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20090910 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091210 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20091210 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20100219 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100309 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100326 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4486447 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130402 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20200402 Year of fee payment: 10 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |